1. Home
  2. OCUL vs ONDS Comparison

OCUL vs ONDS Comparison

Compare OCUL & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • ONDS
  • Stock Information
  • Founded
  • OCUL 2006
  • ONDS 2014
  • Country
  • OCUL United States
  • ONDS United States
  • Employees
  • OCUL N/A
  • ONDS N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • ONDS Telecommunications Equipment
  • Sector
  • OCUL Health Care
  • ONDS Telecommunications
  • Exchange
  • OCUL Nasdaq
  • ONDS Nasdaq
  • Market Cap
  • OCUL 2.3B
  • ONDS 2.2B
  • IPO Year
  • OCUL 2014
  • ONDS N/A
  • Fundamental
  • Price
  • OCUL $11.48
  • ONDS $6.75
  • Analyst Decision
  • OCUL Strong Buy
  • ONDS Strong Buy
  • Analyst Count
  • OCUL 9
  • ONDS 4
  • Target Price
  • OCUL $22.63
  • ONDS $7.25
  • AVG Volume (30 Days)
  • OCUL 3.1M
  • ONDS 52.8M
  • Earning Date
  • OCUL 11-04-2025
  • ONDS 11-13-2025
  • Dividend Yield
  • OCUL N/A
  • ONDS N/A
  • EPS Growth
  • OCUL N/A
  • ONDS N/A
  • EPS
  • OCUL N/A
  • ONDS N/A
  • Revenue
  • OCUL $56,664,000.00
  • ONDS $16,131,404.00
  • Revenue This Year
  • OCUL N/A
  • ONDS $284.53
  • Revenue Next Year
  • OCUL $17.75
  • ONDS $189.78
  • P/E Ratio
  • OCUL N/A
  • ONDS N/A
  • Revenue Growth
  • OCUL N/A
  • ONDS 75.16
  • 52 Week Low
  • OCUL $5.79
  • ONDS $0.57
  • 52 Week High
  • OCUL $13.85
  • ONDS $11.70
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 45.90
  • ONDS 42.22
  • Support Level
  • OCUL $11.38
  • ONDS $6.47
  • Resistance Level
  • OCUL $11.78
  • ONDS $8.32
  • Average True Range (ATR)
  • OCUL 0.50
  • ONDS 0.97
  • MACD
  • OCUL -0.01
  • ONDS -0.38
  • Stochastic Oscillator
  • OCUL 30.89
  • ONDS 6.00

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About ONDS Ondas Holdings Inc.

Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.

Share on Social Networks: